pharma · Mantle Cell Lymphoma · Colon cancer
Telethon Foundation
Fondazione Telethon ETS
Telethon Foundation clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- roma, IT
- Founded
- 1990
- Employees
- 343
- Programs
- 162
- Drugs
- 285
- Patents
- 0
Telethon Foundation projects
3 ClinicalTrials.gov programs sponsored by Telethon Foundation.
Telethon Foundation has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
A Multicentre for High-Risk, Surgically Resectabl…
Fondazione Telethon ETS
High-Risk, Surgically Resectable Melanoma
1 trial -
HepaVac-201
Fondazione Telethon ETS
Hepatocellular carcinoma
1 trial -
R4-FOUR-PET
Fondazione Telethon ETS
Advanced solid neoplasm (breast, lung, colon, ovary, pancreas) characterized by positive CXCR4 expression by immunohistochemistry
1 trial
Frequently asked questions
How many clinical projects does Telethon Foundation have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.